Metis Global Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Sell
5,623
-684
-11% -$62.8K 0.01% 573
2025
Q4
$567K Sell
6,307
-4,349
-41% -$412K 0.01% 570
2025
Q3
$1.05M Sell
10,656
-486
-4% -$48.2K 0.02% 458
2025
Q2
$1.02M Sell
11,142
-3,141
-22% -$304K 0.03% 460
2025
Q1
$1.62M Buy
14,283
+1,922
+16% +$206K 0.05% 354
2024
Q4
$1.31M Buy
12,361
+476
+4% +$51.1K 0.04% 375
2024
Q3
$1.28M Buy
11,885
+671
+6% +$73.2K 0.04% 391
2024
Q2
$1.22M Buy
11,214
+305
+3% +$36K 0.04% 372
2024
Q1
$1.44M Sell
10,909
-2,108
-16% -$263K 0.05% 340
2023
Q4
$1.58M Sell
13,017
-10
-0.1% -$1.12K 0.06% 290
2023
Q3
$1.46M Buy
13,027
+2,234
+21% +$284K 0.07% 291
2023
Q2
$1.57M Buy
10,793
+3,093
+40% +$420K 0.08% 251
2023
Q1
$995K Buy
7,700
+2,146
+39% +$269K 0.06% 329
2022
Q4
$708K Buy
5,554
+1,509
+37% +$175K 0.06% 344
2022
Q3
$422K Buy
4,045
+345
+9% +$37.9K 0.07% 339
2022
Q2
$389K Buy
3,700
+394
+12% +$46.7K 0.06% 356
2022
Q1
$423K Buy
3,306
+1,427
+76% +$172K 0.05% 336
2021
Q4
$232K Buy
+1,879
New +$246K 0.06% 331

Other funds holding ZBH

Metis Global Partners's ZBH Position: Q1 2026 in Review

Metis Global Partners reduced its Zimmer Biomet (ZBH) stake by 11% in Q1 2026, selling an estimated $62.8K and leaving 5,623 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #573.

Metis Global Partners first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.62M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Metis Global Partners held 5,623 shares of Zimmer Biomet worth $508K as of Q1 2026.
  • Metis Global Partners sold 684 Zimmer Biomet shares in Q1 2026, an estimated $62.8K.
  • Zimmer Biomet made up 0.01% of Metis Global Partners's portfolio in Q1 2026, its #573 holding.
  • Metis Global Partners first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
  • Metis Global Partners's Zimmer Biomet position peaked at $1.62M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.